Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Abiomed Inc (ABMD)
Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,180,568
  • Shares Outstanding, K 45,091
  • Annual Sales, $ 1,032 M
  • Annual Income, $ 136,510 K
  • 60-Month Beta 1.40
  • Price/Sales 16.64
  • Price/Cash Flow 74.88
  • Price/Book 11.16
Trade ABMD with:
  • Price/Earnings ttm 78.68
  • Earnings Per Share ttm 4.84
  • Most Recent Earnings 1.30 on 11/01/22
  • Next Earnings Date 02/02/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 3.67%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 1.03
  • Number of Estimates 5
  • High Estimate 1.20
  • Low Estimate 0.67
  • Prior Year 1.13
  • Growth Rate Est. (year over year) -8.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
376.55 +1.19%
on 12/02/22
381.80 -0.20%
on 12/08/22
+4.40 (+1.17%)
since 11/21/22
3-Month
237.44 +60.47%
on 10/12/22
381.99 -0.25%
on 11/01/22
+128.21 (+50.71%)
since 09/21/22
52-Week
219.85 +73.31%
on 06/16/22
381.99 -0.25%
on 11/01/22
+48.82 (+14.70%)
since 12/21/21

Most Recent Stories

More News
Is It Too Late to Buy Johnson & Johnson's Stock?

This healthcare juggernaut's recent quarterly results prove just how strong its business is.

ABMD : 381.02 (+0.06%)
JNJ : 154.53 (-0.56%)
Investors Are Keeping This Healthcare Stock Long-Term

Despite an uncertain macro environment, healthcare giant Johnson & Johnson (JNJ) reported outstanding results in 2022, reflecting its business segments' continued strength. Moreover, the company has a...

ABMD : 381.02 (+0.06%)
BMY : 50.42 (+0.52%)
JNJ : 154.53 (-0.56%)
NVO : 96.64 (-0.18%)
NVS : 96.31 (+0.40%)
4 Best Pharma Stocks to Buy for the Long Haul

With the persistent rise in lifestyle diseases, the pharmaceutical industry is well poised for strong growth in the long term. Also, with the Fed likely to keep increasing the interest rates, the economy...

ABMD : 381.02 (+0.06%)
AZN : 63.27 (-0.38%)
BMY : 50.42 (+0.52%)
CINC : 29.06 (-0.48%)
JNJ : 154.53 (-0.56%)
NVS : 96.31 (+0.40%)
3 Large-Cap Stocks You Can Buy for Under $200

The recent financial turmoil from several bank failures, the Fed’s persistent hawkish stance to battle stubborn inflation, and renewed recession worries have kept the stock market highly volatile lately....

ABMD : 381.02 (+0.06%)
JNJ : 154.53 (-0.56%)
MRK : 103.64 (-0.23%)
TSM : 100.12 (+0.84%)
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

Sector ETF report for XHE

XHE : 77.31 (+0.63%)
ISRG : 310.59 (-0.31%)
DXCM : 117.44 (-1.22%)
ABMD : 381.02 (+0.06%)
IHI : 50.71 (+0.18%)
MDEV : 18.70 (+0.14%)
Want to Retire a Millionaire? 2 Stocks to Buy Now

The recent bank failures have increased the likelihood of a recession, with many economists increasing the odds of an economic slump in the next 12 months. Amid this backdrop, investors could buy fundamentally...

ABMD : 381.02 (+0.06%)
JNJ : 154.53 (-0.56%)
PFE : 28.75 (+0.42%)
3 Stocks That Could Deliver Healthy Returns This Year

The stock market will likely stay under pressure this year, with stubborn inflation and elevated interest rates. However, the Fed’s decision could largely be influenced by concerns about the recent banking...

ABMD : 381.02 (+0.06%)
ABT : 104.69 (+0.62%)
CSII : 20.00 (+0.15%)
HUM : 478.11 (-0.46%)
JNJ : 154.53 (-0.56%)
This Big Pharma Stock Is a Clear Buy in 2023

With interest rates expected to be higher than originally anticipated and fears of a looming recession weighing heavily on investors’ decisions, the stock market is expected to remain under pressure...

ABMD : 381.02 (+0.06%)
BMY : 50.42 (+0.52%)
JNJ : 154.53 (-0.56%)
NVO : 96.64 (-0.18%)
NVS : 96.31 (+0.40%)
3 Powerhouse Stocks to Buy in 2023

As the Fed is expected to raise interest rates higher than expected, the revived recession fears will keep the stock market under pressure in the upcoming months. Thus, it could be wise to scoop up shares...

ABMD : 381.02 (+0.06%)
AZO : 2,610.86 (-0.83%)
C : 48.96 (+0.95%)
GS : 351.76 (+2.07%)
HUM : 478.11 (-0.46%)
JNJ : 154.53 (-0.56%)
3 Hot Dividend Stocks to Buy Now and Hold Forever

Due to a barrage of strong macroeconomic data, the Federal Reserve has expressed the need to keep interest rates elevated. This is expected to keep the market volatile. Amid this backdrop, it might be...

ABMD : 381.02 (+0.06%)
ARC : 2.97 (-1.16%)
JNJ : 154.53 (-0.56%)
NVS : 96.31 (+0.40%)
SDY : 121.41 (-0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Abiomed Inc. is engaged in developing, manufacturing and marketing of medical products, designed to assist or replace the pumping function of the failing heart.

See More

Key Turning Points

3rd Resistance Point 382.13
2nd Resistance Point 381.71
1st Resistance Point 381.36
Last Price 381.02
1st Support Level 380.59
2nd Support Level 380.17
3rd Support Level 379.82

See More

52-Week High 381.99
Last Price 381.02
Fibonacci 61.8% 320.05
Fibonacci 50% 300.92
Fibonacci 38.2% 281.78
52-Week Low 219.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar